We are international
Donate
TEXT SIZE   


Dr. Morgan - Optimising Bone Disease In Myeloma; Zoledronic Acid Plus Thalidomide Combinations Improves Survival and Bone Endpoints: Results of the MRC Myeloma IX Trial
Gareth Morgan, MD
The Institute of Cancer Research
London, United Kingdom
12.02.10


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles